Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

ICERs favour long-term insulin glargine for diabetes

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Grima DT, Thompson MF, Sauriol L.Modelling cost effectiveness of insulin glargine for the treatment of type 1 and type 2 diabetes in Canada. PharmacoEconomics 25: 253-266, No. 3, 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    ICERs favour long-term insulin glargine for diabetes. Pharmacoecon. Outcomes News 524, 7 (2007). https://doi.org/10.2165/00151234-200705240-00010

    Download citation

    Keywords

    • Insulin Glargine
    • Emergency Room Visit
    • Baseline HbA1c
    • United Kingdom Prospective Diabetes Study
    • Canadian Dollar